Influx Healthtech Limited
Bookbuilding IPO · NSE
- Price band
- ₹91 - ₹96
- Lot size
- 1,200 shares
- Issue amount
- ₹58.57 cr
- Total subscription
- 187.32×
- Opens
- 18 Jun 2025
- Closes
- 20 Jun 2025
- Allotment
- 23 Jun 2025
- Listing
- 25 Jun 2025
Offer at a glance
Issue overview
- Issue size
- 61,00,800 shares
- Face value
- ₹10 per share
- Minimum investment
- ₹1,09,200
- Fresh issue
- ₹48 cr
- Offer for sale
- ₹10.56 cr
- Registrar
- Maashitla Securities Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,15,200
- Issue type
- Bookbuilding IPO
- Shares before issue
- 1,81,50,000
- Shares after issue
- 2,31,50,400
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,200 | ₹1,15,200 |
| HNI | 2 | 2,400 | ₹2,30,400 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Application-wise demand
| Category | Reserved applications | Applied applications |
|---|---|---|
| QIB | — | 99 |
| NIB | — | 21,204 |
| RETAIL | — | 1,99,035 |
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 11.13 | 1,534.26 |
| RETAIL | 19.48 | 2,292.88 |
Financial performance
Company financials
In Crores · Reported periods may include interim results.
Key performance indicators
| Metric | Mar-25 | Mar-24 | Mar-23 |
|---|---|---|---|
| EPS | 7.36 | 6.13 | 3.96 |
| ROE | 36.98 | 48.85 | 61.76 |
| ROCE | 49.17 | 65.58 | 78.6 |
| RONW | 36.98 | 36.98 | 61.76 |
| PRE IPO(PE) | 13.04 | 0 | 0 |
| POST IPO(PE) | 16.63 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Influx Healthtech Limited, established in September 2020, is a healthcare-focused company that provides contract manufacturing services. It operates as a trusted CDMO (Contract Development and Manufacturing Organization), serving clients across various sectors. The company runs three manufacturing units located in Thane, Maharashtra, with facility sizes of 9,676 sq. ft., 13,000 sq. ft., and 14,000 sq. ft. Its product range includes tablets, capsules, powders, liquid orals, softgels, lozenges, jellies, gummies, oral dispersible films, effervescent tablets, liquid-fill capsules, candies, gym and sports supplements, as well as skincare, body care, hair care, beard care products, face masks, and soaps. It also manufactures ayurvedic and herbal formulations, veterinary feed supplements, and homecare products. The company supports nutraceutical and cosmetic businesses by handling the entire process from product development to manufacturing and regulatory assistance, allowing clients to concentrate on formulation and market launch. As of June 11, 2025, Influx Healthtech Limited employs 163 full-time staff members.
Strengths
- Wide Product Range – Offers products in pharma, nutraceuticals, and cosmetics
- Trusted Client Base – Strong relationships with well-known health and wellness brands
- Strong Quality Control – Follows GMP, FSSAI, and other standards with strict quality checks
Risk factors
- High Competition – Competes with big CDMO players like Jubilant and Divi’s Labs
- Raw Material Price Fluctuations – Changing input costs can reduce profit margins
- Dependence on Key Clients – Losing major customers could impact business stability.
Promoters
Mr. Munir Abdul Ganee Chandniwala
Mrs. Shirin Munir Ahmed Chandniwala
Mr. Abdul Ganee Abdul Rasul Chandniwala
Registrar & documents
Lead manager
Rarever Financial Advisors Private Limited
Registrar & contacts
Maashitla Securities Private Limited
[email protected]Official registrar portal ↗Check allotment status on registrar →Registered office
109, Ghanshyam Enclave Premises Co-op Soc Plot No. 856, Laljipada Kandivali West, Mumbai, Maharashtra
+91 7045997809
[email protected]Company website ↗Frequently Asked Questions
What is Influx Healthtech IPO GMP today?
As of today, Influx Healthtech IPO Grey Market Premium (GMP) is reported at +₹20 per share. Based on the upper price band of ₹96, the estimated listing price is ₹116 (+20.8% expected listing gain). Please note that GMP is an unofficial market estimate for sentiment tracking and does not guarantee the actual listing price.
What is the lot size and minimum investment for Influx Healthtech IPO?
The minimum bid lot size for Influx Healthtech IPO is 1,200 shares. At the cut-off price of ₹96 per share, retail investors need a minimum application amount of ₹1,15,200 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).
When will Influx Healthtech IPO allotment status be announced?
The allotment status for Influx Healthtech IPO is scheduled to be finalized on 23 Jun 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Maashitla Securities Private Limited's official portal or via BSE/NSE allotment portals.
How can I check Influx Healthtech IPO allotment status online by PAN?
To check Influx Healthtech IPO allotment status: 1) Visit the registrar portal (Maashitla Securities Private Limited) or the BSE IPO allotment page. 2) Select 'Influx Healthtech Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.
Explore More IPO Analysis & Live Tools
Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.